{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T17:11:52Z","timestamp":1784913112163,"version":"3.55.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.rmed.2017.11.020","type":"journal-article","created":{"date-parts":[[2017,12,2]],"date-time":"2017-12-02T04:55:01Z","timestamp":1512190501000},"page":"42-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Pulmonary arterial hypertension in the setting of scleroderma is different than in the setting of lupus: A review"],"prefix":"10.1016","volume":"134","author":[{"given":"Isabel S.","family":"Bazan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kofi A.","family":"Mensah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasiia A.","family":"Rudkovskaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5780-2931","authenticated-orcid":false,"given":"Percy K.","family":"Adonteng-Boateng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica L.","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenore","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9462-8103","authenticated-orcid":false,"given":"Wassim H.","family":"Fares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25 Suppl","key":"10.1016\/j.rmed.2017.11.020_bib1","doi-asserted-by":"crossref","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","article-title":"Updated clinical classification of pulmonary hypertension","volume":"62","author":"Simonneau","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"25 Suppl","key":"10.1016\/j.rmed.2017.11.020_bib2","doi-asserted-by":"crossref","first-page":"D42","DOI":"10.1016\/j.jacc.2013.10.032","article-title":"Definitions and diagnosis of pulmonary hypertension","volume":"62","author":"Hoeper","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.rmed.2017.11.020_bib3","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1378\/chest.14-0793","article-title":"Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report","volume":"146","author":"Taichman","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2017.11.020_bib4","doi-asserted-by":"crossref","unstructured":"Gali\u00e8 N, Humbert M, Vachiery J-L, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), Intern\u2026 2015.","DOI":"10.1183\/13993003.01032-2015"},{"issue":"12","key":"10.1016\/j.rmed.2017.11.020_bib5","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1161\/CIRCULATIONAHA.113.004555","article-title":"Immune dysregulation and endothelial dysfunction in pulmonary arterial hypertension: a complex interplay","volume":"129","author":"Huertas","year":"2014","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.rmed.2017.11.020_bib6","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.amjcard.2016.02.049","article-title":"Review of the ongoing story of appetite suppressants, serotonin pathway, and pulmonary vascular disease","volume":"117","author":"Bazan","year":"2016","journal-title":"Am. J. Cardiol."},{"issue":"7","key":"10.1016\/j.rmed.2017.11.020_bib7","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1164\/rccm.201403-0442OC","article-title":"Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis","volume":"190","author":"Becker","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2017.11.020_bib8","series-title":"Robbins and Cotran Pathologic Basis of Disease","author":"Robbins","year":"2010"},{"issue":"5","key":"10.1016\/j.rmed.2017.11.020_bib9","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1172\/JCI1910","article-title":"Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension","volume":"101","author":"Lee","year":"1998","journal-title":"J. Clin. Invest"},{"issue":"4","key":"10.1016\/j.rmed.2017.11.020_bib10","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ccm.2013.08.009","article-title":"Pathology of pulmonary hypertension","volume":"34","author":"Tuder","year":"2013","journal-title":"Clin. Chest Med."},{"issue":"9","key":"10.1016\/j.rmed.2017.11.020_bib11","doi-asserted-by":"crossref","first-page":"e106703","DOI":"10.1371\/journal.pone.0106703","article-title":"Functional changes in pulmonary arterial endothelial cells associated with BMPR2 mutations","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"issue":"25 0","key":"10.1016\/j.rmed.2017.11.020_bib12","doi-asserted-by":"crossref","first-page":"D4","DOI":"10.1016\/j.jacc.2013.10.025","article-title":"Relevant issues in the pathology and pathobiology of pulmonary hypertension","volume":"62","author":"Tuder","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.rmed.2017.11.020_bib13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/humu.20285","article-title":"Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension","volume":"27","author":"Machado","year":"2006","journal-title":"Hum. Mutat."},{"issue":"12","key":"10.1016\/j.rmed.2017.11.020_bib14","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/humu.22904","article-title":"Pulmonary arterial hypertension: a current perspective on established and emerging molecular genetic defects","volume":"36","author":"Machado","year":"2015","journal-title":"Hum. Mutat."},{"issue":"38","key":"10.1016\/j.rmed.2017.11.020_bib15","doi-asserted-by":"crossref","first-page":"33134","DOI":"10.1074\/jbc.M111.274100","article-title":"Bone morphogenetic protein receptor II is a novel mediator of endothelial nitric-oxide synthase activation","volume":"286","author":"Gangopahyay","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"17","key":"10.1016\/j.rmed.2017.11.020_bib16","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1161\/01.CIR.0000033830.36431.46","article-title":"Stimulation of Id1 expression by bone morphogenetic protein is sufficient and necessary for bone morphogenetic protein-induced activation of endothelial cells","volume":"106","author":"Valdimarsdottir","year":"2002","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.rmed.2017.11.020_bib17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.mvr.2012.03.010","article-title":"Effects of bone morphogenetic protein 2 on human umbilical vein endothelial cells","volume":"84","author":"Finkenzeller","year":"2012","journal-title":"Microvasc. Res."},{"issue":"25 Suppl","key":"10.1016\/j.rmed.2017.11.020_bib18","doi-asserted-by":"crossref","first-page":"D22","DOI":"10.1016\/j.jacc.2013.10.027","article-title":"Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology","volume":"62","author":"Vonk-Noordegraaf","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"12 Suppl S","key":"10.1016\/j.rmed.2017.11.020_bib19","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/j.jacc.2004.02.029","article-title":"Cellular and molecular pathobiology of pulmonary arterial hypertension","volume":"43","author":"Humbert","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1 Suppl","key":"10.1016\/j.rmed.2017.11.020_bib20","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jacc.2009.04.006","article-title":"Inflammation, growth factors, and pulmonary vascular remodeling","volume":"54","author":"Hassoun","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"12","key":"10.1016\/j.rmed.2017.11.020_bib21","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1164\/rccm.200909-1331PP","article-title":"Systemic sclerosis-associated pulmonary arterial hypertension","volume":"181","author":"Le Pavec","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2017.11.020_bib22","doi-asserted-by":"crossref","first-page":"854941","DOI":"10.1155\/2012\/854941","article-title":"Pulmonary arterial hypertension in systemic lupus erythematosus: current status and future direction","volume":"2012","author":"Dhala","year":"2012","journal-title":"Clin. Dev. Immunol."},{"issue":"5","key":"10.1016\/j.rmed.2017.11.020_bib23","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1183\/09031936.00104706","article-title":"Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension","volume":"29","author":"Perros","year":"2007","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.rmed.2017.11.020_bib24","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1164\/ajrccm.165.4.2012112","article-title":"Chemokine RANTES in severe pulmonary arterial hypertension","volume":"165","author":"Dorfmuller","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.rmed.2017.11.020_bib25","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.hfc.2012.04.001","article-title":"Pulmonary arterial hypertension in connective tissue diseases","volume":"8","author":"Mathai","year":"2012","journal-title":"Heart Fail Clin."},{"issue":"2","key":"10.1016\/j.rmed.2017.11.020_bib26","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/art.39432","article-title":"Characteristics and survival of Anti-U1 RNP antibody-positive patients with connective tissue disease-associated pulmonary arterial hypertension","volume":"68","author":"Sobanski","year":"2016","journal-title":"Arthritis Rheumatol."},{"issue":"122","key":"10.1016\/j.rmed.2017.11.020_bib27","first-page":"277","article-title":"Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus. European respiratory review","volume":"20","author":"Johnson","year":"2011","journal-title":"Offic. J. Eur. Respir. Soc."},{"issue":"1","key":"10.1016\/j.rmed.2017.11.020_bib28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/art.23177","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States","volume":"58","author":"Helmick","year":"2008","journal-title":"Part I. Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.rmed.2017.11.020_bib29","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.rmed.2017.11.020_bib30","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.rmed.2017.11.020_bib31","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1378\/chest.09-1140","article-title":"Pulmonary arterial hypertension: baseline characteristics from the REVEAL registry","volume":"137","author":"Badesch","year":"2010","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.rmed.2017.11.020_bib32","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1378\/chest.10-0075","article-title":"The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries","volume":"139","author":"Frost","year":"2011","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.rmed.2017.11.020_bib33","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1378\/chest.11-1460","article-title":"An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL registry","volume":"142","author":"Benza","year":"2012","journal-title":"Chest"},{"issue":"134","key":"10.1016\/j.rmed.2017.11.020_bib34","first-page":"450","article-title":"The changing landscape of pulmonary arterial hypertension and implications for patient care. European respiratory review","volume":"23","author":"Hoeper","year":"2014","journal-title":"Offic. J. Eur. Respir. Soc."},{"key":"10.1016\/j.rmed.2017.11.020_bib35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/CRD.0b013e3181cbcde7","article-title":"Pulmonary arterial hypertension in connective tissue diseases","volume":"18","author":"Goldberg","year":"2010","journal-title":"Cardiol. Rev."},{"issue":"12","key":"10.1016\/j.rmed.2017.11.020_bib36","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1002\/art.21433","article-title":"Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study","volume":"52","author":"Hachulla","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.rmed.2017.11.020_bib37","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/ard.62.11.1088","article-title":"Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach","volume":"62","author":"Mukerjee","year":"2003","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.rmed.2017.11.020_bib38","first-page":"1005","article-title":"Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease","volume":"34","author":"Launay","year":"2007","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.rmed.2017.11.020_bib39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/ard.2006.057760","article-title":"Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis","volume":"67","author":"de Groote","year":"2008","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.rmed.2017.11.020_bib40","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/art.23463","article-title":"Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: a controlled study of 100 consecutive patients","volume":"58","author":"Meune","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.rmed.2017.11.020_bib41","first-page":"1221","article-title":"Pulmonary hypertension: diagnostic and therapeutic challenges","volume":"11","author":"Bazan","year":"2015","journal-title":"Ther. Clin. risk Manag."},{"issue":"2","key":"10.1016\/j.rmed.2017.11.020_bib42","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/art.10775","article-title":"Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement","volume":"48","author":"Steen","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"suppl 1","key":"10.1016\/j.rmed.2017.11.020_bib43","first-page":"i1","article-title":"Recommendations on the management of pulmonary hypertension in clinical practice","volume":"86","author":"British Cardiac Society Guidelines and Medical Practice Committee aabtBTSatBSoR","year":"2001","journal-title":"Heart"},{"issue":"12","key":"10.1016\/j.rmed.2017.11.020_bib44","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1002\/art.38172","article-title":"Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension","volume":"65","author":"Khanna","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.rmed.2017.11.020_bib45","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.semarthrit.2013.08.002","article-title":"Screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension: a systematic review","volume":"43","author":"Gladue","year":"2014","journal-title":"Semin. arthritis Rheum."},{"issue":"7","key":"10.1016\/j.rmed.2017.11.020_bib46","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1002\/art.21131","article-title":"The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study)","volume":"52","author":"Wigley","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.rmed.2017.11.020_bib47","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/rheumatology\/keh067","article-title":"Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis","volume":"43","author":"Mukerjee","year":"2004","journal-title":"Rheumatology"},{"issue":"10","key":"10.1016\/j.rmed.2017.11.020_bib48","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.rmed.2017.11.020_bib49","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972-2002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann. Rheum. Dis."},{"issue":"25 Suppl","key":"10.1016\/j.rmed.2017.11.020_bib50","doi-asserted-by":"crossref","first-page":"D60","DOI":"10.1016\/j.jacc.2013.10.031","article-title":"Updated treatment algorithm of pulmonary arterial hypertension","volume":"62","author":"Galie","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.rmed.2017.11.020_bib51","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1378\/chest.10-0260","article-title":"Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype","volume":"138","author":"Chung","year":"2010","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.rmed.2017.11.020_bib52","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1378\/chest.13-3014","article-title":"Unique predictors of mortality in patients with pulmonary arterial hypertension associated with systemic sclerosis in the REVEAL registry","volume":"146","author":"Chung","year":"2014","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.rmed.2017.11.020_bib53","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1378\/chest.12-0653","article-title":"Survival in systemic sclerosis with pulmonary arterial hypertension has not improved in the modern era","volume":"144","author":"Rubenfire","year":"2013","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.rmed.2017.11.020_bib54","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1055\/s-2003-41089","article-title":"Pulmonary hypertension in the collagen vascular diseases","volume":"24","author":"Tanoue","year":"2003","journal-title":"Semin. Respir. Crit. care Med."},{"key":"10.1016\/j.rmed.2017.11.020_bib55","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1001\/jama.2012.12347","article-title":"Pulmonary hypertension","volume":"308","author":"Shah","year":"2012","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.rmed.2017.11.020_bib56","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/rheumatology\/kep203","article-title":"Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus","volume":"48","author":"Prabu","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.rmed.2017.11.020_bib57","unstructured":"Control CfD. Systemic Lupus Erythematosus."},{"key":"10.1016\/j.rmed.2017.11.020_bib58","doi-asserted-by":"crossref","first-page":"328435","DOI":"10.1155\/2015\/328435","article-title":"Lupus-associated pulmonary arterial hypertension: variable course and importance of prompt recognition","volume":"2015","author":"Mensah","year":"2015","journal-title":"Case Rep. Med."},{"issue":"5","key":"10.1016\/j.rmed.2017.11.020_bib59","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00296-012-2525-y","article-title":"Pulmonary hypertension in systemic lupus erythematosus: a systematic review and analysis of 642 cases in Chinese population","volume":"33","author":"Xia","year":"2013","journal-title":"Rheumatol. Int."},{"issue":"2","key":"10.1016\/j.rmed.2017.11.020_bib60","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1164\/rccm.200806-953OC","article-title":"Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era","volume":"179","author":"Condliffe","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.rmed.2017.11.020_bib61","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/art.23303","article-title":"Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases","volume":"58","author":"Jais","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.rmed.2017.11.020_bib62","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1378\/chest.11-0793","article-title":"Inflammation in pulmonary arterial hypertension","volume":"141","author":"Price","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2017.11.020_bib63","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1378\/chest.130.1.182","article-title":"Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension","volume":"130","author":"Sanchez","year":"2006","journal-title":"Chest"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611117304055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611117304055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:38:41Z","timestamp":1760614721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611117304055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":63,"alternative-id":["S0954611117304055"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2017.11.020","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary arterial hypertension in the setting of scleroderma is different than in the setting of lupus: A review","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2017.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}